IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, today announced is pleased to announce its participation in The ...
micro-segmentation of networks and centralized security monitoring. “We’re looking forward to a strong 2025,” Gault continued. “We foresee further strengthening our commercial growth along with some ...